CA - AirBoss of America announces $410M contract awarded to Access Bio
- AirBoss of America ( OTCQX:ABSSF ) announced that the Defense Logistics Agency, or DLA, has awarded an Indefinite Delivery/Indefinite Quantity, or IDIQ, contract valued at up to $410M to Access Bio, an industry leader in medical testing and diagnostics, supported by a U.S. coalition including AirBoss Defense Group, or ADG, Maddox Defense, and a network of US test kit component suppliers.
- This competitively awarded contract for the delivery of Made in America COVID test kits supports the US Government's on-going response to the COVID pandemic.
- The award demonstrates the US Government's strategic shift toward an American-made and sourced policy that is intended to ensure domestic industrial base capability and capacity in areas critical to the US response to any national emergency.
- Access Bio has already received, and commenced deliveries under, the first order of approximately one half of this IDIQ contract, valued at $205M.
- ADG expects to generate $19M in revenue during the next six months as this order is completed, and up to an aggregate of $38M over the lifetime of the contract.
For further details see:
AirBoss of America announces $410M contract awarded to Access Bio